Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion.

Zhen Liu Xiaomei Xue Jie Lu Nicola DalbethHan QiQing YuCan Wang Mingshu SunLingling CuiZhen LiuYuwei HeXuan YuanYing ChenXiaoyu ChengLidan MaHailong LiAichang JiShuhui Hu Zijing Ran Robert Terkeltaub Changgui Li

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2022)

Compared to LDFeb, LDBen has superior urate-lowering efficacy and similar safety in treating relatively young and healthy patients with renal uric acid underexcretion-type gout.

Keyphrases

uric acid
low dose
metabolic syndrome

high dose
clinical trial

study protocol
randomized controlled trial

middle aged
double blind